Skip to main content

Table 2 Quality of life 24 months after initial COVID- 19 infection, in a subpopulation of 141 participants who completed the M24 questionnaire

From: Trajectories of persisting Covid- 19 symptoms up to 24 months after acute infection: findings from the Predi-Covid cohort study

Variable

Total study population (N= 141)

T1: Mild symptoms, fast resolution (N = 87)

T2: Elevated and persisting symptoms (N= 54)

p value (T1 vs T2)

Stress level (PSS4 score)

5.3 ± 3.4

4.5 ± 3.2

6.6 ± 3.4

0.001

Participants with high stress level N(%)

62(43.97)

31(35.63)

31(57.41)

0.015

Fatigue level (FSS9 score)

29.1 ± 16.4

22.1 ± 13.3

40.3 ± 14.8

< 0.001

Participants with high fatigue level, N(%)

52(36.88)

17(19.54)

35(64.81)

< 0.001

Anxiety level (GAD7 score)

4[0, 21]

1[0,21]

6.5[0,21]

< 0.001

Participants with high anxiety level, N(%)

17(12.06)

4(4.60)

13(24.07)

0.001

Sleep (PSQI)

5[0,20]

5[0,14]

8[2,20]

< 0.001

Poor sleep, N(%)

86(60.56)

45(51.14)

41(75.93)

0.004

Respiratory quality of life (VQ11)

14[11,47]

12[11,34]

19.5[11,47]

< 0.001

Altered respiratory quality of life, N(%)

27(19.15)

4(4.60)

23(42.59)

< 0.001

Life rhythm recovered as before COVID- 19 (Yes)

132(88.00)

88(97.78)

44(73.33)

< 0.001

Professional activity unrecovered, N(%)

6(4.00)

1(1.11)

5(8.33)

0.038

Relationship with family or friends worsened, N(%)

10(6.67)

1(1.11)

9(15.00)

0.001

No symptoms anymore, N(%)

75(50.00)

69(76.67)

6(10.00)

< 0.001

Symptoms occurring under the form of crisis, N(%)

40(26.67)

10(11.11)

30(50.00)

< 0.001

Symptoms being constants, N(%)

35(23.33)

11(12.22)

24(40.00)

< 0.001

  1. P-values are determined using the student t-test or Wilcoxon test for continuous variables